Inari Medical, Inc. Common Stock
NARI
NARI: Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism. The company generates revenue from the sale of ClotTriever and FlowTriever systems directly to hospitals located in the United States. Majority of revenue is generated from FlowTriever system.
moreShow NARI Financials
Recent trades of NARI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NARI's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: System for treating embolism and associated devices and methods Sep. 05, 2023
-
Patent Title: Hemostasis valves and methods of use Jul. 11, 2023
-
Patent Title: Hemostasis valves and methods of use Jul. 11, 2023
-
Patent Title: Methods and apparatus for treating embolism May. 16, 2023
-
Patent Title: System for treating embolism and associated devices and methods May. 09, 2023
-
Patent Title: System for treating embolism and associated devices and methods Jan. 24, 2023
-
Patent Title: System for treating embolism and associated devices and methods Jan. 17, 2023
-
Patent Title: Method for treating vascular occlusion Dec. 20, 2022
-
Patent Title: Catheter shaft and associated devices, systems, and methods Sep. 06, 2022
-
Patent Title: Single insertion delivery system for treating embolism and associated systems and methods Oct. 26, 2021
-
Patent Title: Device and method for treating vascular occlusion Oct. 19, 2021
-
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jul. 13, 2021
-
Patent Title: Methods and apparatus for treating embolism Jul. 13, 2021
-
Patent Title: Hemostasis valves and methods of use May. 11, 2021
-
Patent Title: Devices and methods for treating vascular occlusion Feb. 09, 2021
-
Patent Title: Methods and apparatus for treating embolism Jul. 14, 2020
-
Patent Title: Methods and apparatus for treating embolism Mar. 17, 2020
-
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jan. 07, 2020
-
Patent Title: Retraction and aspiration device for treating embolism and associated systems and methods Jul. 16, 2019
-
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jul. 09, 2019
-
Patent Title: Methods and apparatus for treating embolism Jul. 02, 2019
-
Patent Title: Methods and apparatus for treating embolism Mar. 26, 2019
-
Patent Title: Devices and methods for treating vascular occlusion Oct. 16, 2018
-
Patent Title: Device and method for treating vascular occlusion Aug. 14, 2018
-
Patent Title: Methods and apparatus for treating embolism Jun. 26, 2018
-
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Dec. 19, 2017
-
Patent Title: Intravascular treatment of vascular occlusion and associated devices, systems, and methods Jul. 11, 2017
-
Patent Title: Methods and apparatus for treating embolism Aug. 09, 2016
Federal grants, loans, and purchases
Followers on NARI's company Twitter account
Number of mentions of NARI in WallStreetBets Daily Discussion
Recent insights relating to NARI
Recent picks made for NARI stock on CNBC
ETFs with the largest estimated holdings in NARI
Flights by private jets registered to NARI